Kaluza for Gallios software combines cutting edge data acquisition tools with remarkable ease of use to increase efficiency and performance in the cell characterization and analysis workflow of core research laboratories. Researchers at all levels of experience can learn the system quickly using this next generation acquisition software for the Beckman Coulter Gallios cytometer...
Inserm Transfert, the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), and Translational Research Informatics Center (TRI), in the name of Foundation for Biomedical Research and Innovation (FBRI), committed to promote academic translational researches in Japan, announce today an international cooperation agreement to introduce French biomedical- related patents to the Japanese market.
Such collaboration will be developed through translational activities which leads to the results from the basic research to the clinical practice and focus on the promotion of the potential license agreements with companies from the Japanese life science industry. This international alliance marks a significant milestone in strengthening relationships between Inserm Transfert and TRI, two structures from Academia with a prime mission of transferring to the industry for the patients sake...
Asynt reports on how the School of Chemistry at Monash University in Melbourne, Australia has invested in a range of its DrySyn MULTI heating block systems to support its ground breaking synthetic research in photovoltaics, water splitting and nanoimaging.
In order to improve safety in his laboratories, Leone Spiccia, Professor of Chemistry at Monash University sought laboratory apparatus to replace oil bath systems traditionally used for all general syntheses. He comments “After a lengthy evaluation process we decided to switch to DrySyn heating block systems as they are inherently safer to use than heated oil baths, avoiding the risk of oil spillage that can lead to burns when hot or may cause someone to slip over”. Professor Spiccia added “We are using DrySyn products inside our nanoimaging team...
Due to aging population in Europe the number of test volumes are increasing with 7,8% per year. This means an increase of more than 40% of the workload within 5 years time.
At the same time the number of educated technicians is rapidly decreasing. This combination of factors means laboratories need to get the most of out their existing resources, in other words ‘’maximize their productivity’’. For more than 100 years, Sakura Finetek products have been used in histopathology laboratories around the world. To further support laboratories, Sakura offers the SMART Automation product line aimed to maximize the productivity of a laboratory....
Read MoreUMC Utrecht and Quirem Medical to Collaborate on the Development of Holmium Microspheres for Image-Guided Cancer TreatmentMay 20, 2014
Over the next few years, the University Medical Center (UMC) Utrecht and Quirem Medical will be working closely together to maximize the benefits of using holmium microspheres to treat liver cancer patients worldwide.
The unique properties of holmium microspheres will enable effective treatment planning, dosimetry en treatment evaluation, thereby further improving the results of patients who undergo radioembolization. The collaboration will cover ongoing and future clinical research, grant applications, the production of holmium microspheres and the application for CE marking. Financial details of the deal were not disclosed...
Read MoreDMay 20, 2014
Researchers from the Département Environnement et Agro-biotechnologies at the CRP - Gabriel Lippmann in Luxembourg use Nanoparticle Tracking Analysis for toxicology studies
The Département Environnement et Agro-biotechnologies (EVA), of the Centre de Recherche Public - Gabriel Lippmann, Luxembourg, employs NanoSight Nanoparticle Tracking Analysis (NTA) method from Malvern Instruments to perform environmental analysis and toxicological testing of nanoparticles...
To mark its 30th anniversary - Micronic has published a new product range catalogue and launched a new easy access website that offers a wide variety of useful information to organisations involved with safeguarding one of their most valuable assets - their samples.
The new Micronic 2014 catalogue contains all you need to know about sample storage, handling and management. Available in A4 hard copy, or as a pdf download, the catalogue provides photographs and detailed technical information relating to Micronic's comprehensive range of sample storage tubes, racks, accessories and instruments...
Oxford Gene Technology (OGT), The Molecular Genetics Company, has released a new application note detailing the technical evaluation of two DNA labelling kits, where OGT’s CytoSure Genomic DNA Labelling Kits were found to be quicker and more accurate than a leading alternative.
Achieving efficient and uniform labelling of both test and reference DNA samples is critical for aCGH studies, enhancing data accuracy and interpretation. By ensuring greater accuracy, OGT’s kits vastly improve the identification of breakpoints and even the smallest aberrations, providing robust and invaluable insights into the underlying cause of genetic disorders...
The new Zetasizer NanoSampler from Malvern Instruments is a versatile, compact, fully automated sample delivery system for the Zetasizer Nano, the most widely used system for nanoparticle and colloid characterization.
Delivering precise and reproducible automated sample loading, and accommodating up to 96 sample vials, the NanoSampler enables unattended operation of the Zetasizer Nano, to maximize analytical productivity. It is especially suitable for laboratories where reproducibility is critical and where multivariate studies are routine. The new NanoSampler will work with all of the sizing systems in the Zetasizer Nano instrument range. This range includes both exceptionally high performance and entry level systems that measure particle and molecular size using dynamic light scattering, covering a size range from less than one nanometer up to several microns....
TAP Biosystems has announced that its new ambr250™ automated mini bioreactor system has already been chosen by a number of major pharmaceutical, biotech and CRO firms as a high-throughput, scale-down bioreactor model for their process development and optimisation programmes.
The automated ambr250 system, which has independent parallel control of 12 or 24, single-use 250 mL bioreactors, is being sited at the R&D centres of the top Pharma companies across the US and Europe. The system has also been chosen for the Chinese R & D centre of a major European biopharm; a major CRO in the UK and a UK-based biotech company....
Read MoreRapid and Reliable Determination of Phenolic Compounds in SoilMay 19, 2014
Thermo Fisher has developed an efficient and simple high-performance liquid chromatography (HPLC) method with ultraviolet detection for the determination of phenolic compounds (gallic acid, caffeic acid, 4-hydroxybenzoic acid, syringic acid, ferulic acid, salicylic acid, phloroglucinol, cinnamic acid, catechin, quercetin, vanillin, phloridzin, and phloretin) in apple orchard soil.
Application Note (AN) 1077: Determination of Phenolic Compounds in Apple Orchard Soil demonstrates that the entire analysis process, including sample preparation and separation for one soil sample, can be accomplished within 80 minutes using this method combined with an accelerated solvent extractor....
Dutch Software Company GENALICE announced that it has reached an agreement on a multi-million euro capital investment from Redbrae, a consortium of US- and UK-based private equity investors.
The investment consortium has a strong network in the United States, United Kingdom and Middle East. It has been working with GENALICE for the past year. The successful validation and launch of GENALICE MAP, the company’s groundbreaking DNA data processing solution, formed the basis for the latest financial injection that will provide significant backing to accelerate further product development and distribution....
Read MoreHarnessing New Developments in Genomics to Improve Outcome for Children with Poor Prognosis LeukemiaMay 19, 2014
The dramatic improvement in outcome for children with acute lymphoblastic leukemia is one of the major achievements in hematology in the last 40 years. However, while 90% of children with this disease can now be cured, the outlook has not been so good for the less common type of childhood leukemia, acute myeloid leukemia (AML).
Although only 1 in 7 children with leukemia have AML, half of these children will die from their disease. The challenge now is to harness the new developments in genomics to improve the outcome for these children. At the 19th Congress of the European Hematology Association (EHA), we will learn about the state-of-the-art in management of childhood AML. New concepts in the way AML develops and the way AML cells 'hijack' the main sites of normal blood production within the body will be presented....
Latest J Young Brochure contains includes a wide range of new products, including the Vacuum Manifold and Schlenk Line range, Vac Line Cold Traps and Bubblers, a complete range of Sample and Schlenk Flasks and much more.
J Young valves were first developed in 1968 and in March 2010 GPE Scientific Ltd took over ownership of the famous brand. We have built up the J Young product range to offer hundreds of essential products to be used in industrial and academic research facilities and by glassblowers around the world. GPE Scientific are pleased to announce the latest brochure launch for the J Young range which not only contains our most popular items such as the NMR Valve and the High Vacuum Greaseless Stopcocks but also includes a wide range of new products....
EU support boosts development of therapeutic vaccines against Parkinson's and Multiple System Atrophy. AFFiRiS leads consortium.
An international consortium of top European research teams has received significant EU funding for the development of therapeutic vaccines against Parkinson's Disease (PD) and Multiple System Atrophy (MSA). Led by the Austrian biotech company AFFiRiS AG, the consortium will use a novel tandem strategy to advance the development of two therapeutic vaccine candidates in parallel. They are both unique in the potential for disease modification, something which is sorely missing in PD as well as in MSA. Both candidates target a protein called alpha-synuclein, which plays a key role in the onset and progression of PD and MSA. Additionally, the group attempts to identify biomarkers with diagnostic and prognostic value....
The 2013 Jugend Innovativ competition saw Tecan collaborating with HLFS Ursprung and the Stiegl brewery to optimize the HybriScan™D Beer assay (Sigma-Aldrich) for the quality control of beer on an Infinite® M200 PRO multimode reader.
Bernhard Stehrer, a science teacher at HLFS Ursprung, explained: “Students voluntarily participate in the prestigious Jugend Innovativ competition during their leisure time, and decided to investigate the science behind the quality control of beer. Stiegl provided samples for analysis and showed us the methods used in its laboratory, which involve assessment of cultures under a microscope. It can take a long time to acquire sufficient experience to confidently assess cultures this way, and we felt that molecular methods might be faster and easier to learn.”...
Dutch Software Company GENALICE today announced at the 14th Bio-IT World Conference & Expo that it has started discussions with Intel® about a product development as well as a product delivery partnership.
On 12/12 last year, GENALICE launched its groundbreaking DNA processing software; GENALICE MAP. On a simple dual Intel® Xeon® E5 server the company was capable to map the short reads of 42 complete human and 42 full tomato genomes within 24 hours. The software is designed to optimally make use of the modern hardware architecture of these commodity Intel processors....
Quotient Clinical, the Translational Pharmaceutics Company, has announced the extension of its Translational Pharmaceutics™ platform into patient-focused cancer drug development.
Quotient will employ its real-time, flexible manufacturing capabilities to supply specialist oncology centers with drug products to support first-in-patient and proof-of-concept programs. Translational Pharmaceutics integrates real-time drug product manufacturing and clinical testing, using processes that significantly reduce the timelines and cost of early stage drug development....
Sygnature Discovery Limited, the UK’s largest independent integrated drug discovery provider, today announced the appointment of Dr Gerry Thomas to the pivotal role of Director of Business Development.
Board Director, Dr Paul Clewlow, stated, “I am delighted to welcome Gerry Thomas to Sygnature Discovery. Gerry is a very experienced industry professional having spent over 20 years in drug discovery and development at Boots Pharmaceuticals, BASF/Knoll, OSI Pharmaceuticals, Prosidion and Shire Pharmaceuticals. Sygnature Discovery has ambitious plans to expand its customer base and Gerry will be instrumental in promoting Sygnature’s integrated drug discovery capabilities and expertise across Europe and North America....
Waters Corporation (NYSE:WAT) today expanded its family of CORTECS® Columns with the introduction of a new line of 2.7 micron silica-based, solid-core particle columns that set a new standard for HPLC column performance.